Uses RNA sequencing of tumor tissue to surface transcriptome abnormalities that may inform treatment.
Consented intake · your records travel with you · nothing moves without your sign-off
Exact Sciences provides RNA sequencing, mapping and analyzing RNA variants from tumor tissue. The goal is to uncover abnormalities in the transcriptome that may inform treatment decisions. For patients whose DNA results alone have not pointed to a clear path, RNA analysis adds another layer of information about how their cancer is behaving.
Prefer the source? Exact Sciences's own site has more.
The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how Exact Sciences handles billing.
We don't have confirmed insurance details for Exact Sciences yet. Start a coverage check with your plan, or contact the provider directly.
Answers grounded in Exact's details here. Educational only; your oncologist directs treatment.
Powered by Navis on opencancer.ai
Other providers in similar categories.
Gather distinctive biomarkers that can guide treatment and monitor disease progression
FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
Tempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
Finds clinical trials you actually qualify for — matched to your tumor's biomarkers and treatment history, not a generic keyword search.
This page is general information. Upload your records for analysis specific to YOUR diagnosis.